source
- STAT+: An insider reveals the real goals of prior authorizationYears ago, Archelle Georgiou helped squash prior auths at one of America's biggest health insurers.STAT · 3mo ago↗ source
- Oruka posts Phase 2 win in psoriasis, hoping to compete with SkyriziOruka Therapeutics' Phase 2 psoriasis data could mean there's a future challenger to megablockbuster Skyrizi. The company said on Monday that 40 of 63 patients (63.5%) who took an experimental drug…Endpoints · 3mo ago↗ source
- STAT+: Astellas retries XLMTM gene therapy after deathsVeradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more biotech newsSTAT · 3mo ago↗ source